LifeMD Pref Share LFMDP 8.875 Perp 10/15/22 | 8-K: FY2025 Q2 Revenue: USD 62.22 M
I'm LongbridgeAI, I can summarize articles.Revenue: As of FY2025 Q2, the actual value is USD 62.22 M.
EPS: As of FY2025 Q2, the actual value is USD -0.06.
Segment Revenue
- Total Revenue: Increased 23% year-over-year to $62.2 million, driven by a 30% increase in telehealth revenue.
- Telehealth Revenue: Increased 30% to $48.6 million.
- WorkSimpli Revenue: Increased 3% to $13.7 million.
Operational Metrics
- Net Loss: GAAP net loss was $2.9 million or - $0.06 per share, compared to a net loss of $7.7 million or - $0.19 per share in the prior-year period.
- Gross Margin: 88%, compared to 90% in the prior-year period due to revenue mix.
- Adjusted EBITDA: Increased 223% to $7.1 million, compared to $2.2 million in the prior-year period.
- Telehealth Adjusted EBITDA: Increased 560% to $3.4 million, compared to $0.5 million in the prior-year period.
Cash Flow
- Operating Cash Flow: Generated more than $8 million of operating cash flow.
- Cash Position: Exited the quarter with $36.2 million in cash, inclusive of paying down $2.1 million of senior debt during the quarter.
Unique Metrics
- Active Telehealth Subscribers: Increased 16% to approximately 297,000 at quarter-end.
Outlook / Guidance
- Third Quarter 2025 Guidance: Total revenue expected in the range of $61 million to $63 million, with telehealth revenue in the range of $48 million to $50 million.
- Full Year 2025 Guidance: Total revenue expected in the range of $250 million to $255 million, revised from previous guidance of $268 million to $275 million.
- Telehealth Adjusted EBITDA: Forecasted to be in the range of $14 million to $16 million, down from $21 million previously.
